Beskrivelse
Krav
Fullmektig i Norge:
Fullmektig i EP:
2018.06.29, EP 18180906
BARZILAI NIR ET AL: "Metformin as a Tool to Target Aging", CELL METABOLISM, CELL PRESS, UNITED STATES, vol. 23, no. 6, 14 June 2016 (2016-06-14), pages 1060 - 1065, XP029601864, ISSN: 1550-4131, DOI: 10.1016/J.CMET.2016.05.011 (B1)
C.J. GLUECK ET AL: "Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30", METABOLISM, vol. 50, no. 7, 1 July 2001 (2001-07-01), pages 856 - 861, XP055032336, ISSN: 0026-0495, DOI: 10.1053/meta.2001.24192 (B1)
CHEN JIE ET AL: "Metformin extends C. elegans lifespan through lysosomal pathway", ELIFE, vol. 6, 13 October 2017 (2017-10-13), XP002787206 (B1)
FILIPE CABREIRO ET AL: "Metformin Retards Aging in C. elegans by Altering Microbial Folate and Methionine Metabolism", CELL, vol. 153, no. 1, 1 March 2013 (2013-03-01), AMSTERDAM, NL, pages 228 - 239, XP055531462, ISSN: 0092-8674, DOI: 10.1016/j.cell.2013.02.035 (B1)
GEETIKA GARG ET AL: "Antiaging Effect of Metformin on Brain in Naturally Aged and Accelerated Senescence Model of Rat", REJUVENATION RESEARCH, vol. 20, no. 3, 1 June 2017 (2017-06-01), US, pages 173 - 182, XP055529841, ISSN: 1549-1684, DOI: 10.1089/rej.2016.1883 (B1)
WO-A1-2012/012156 (C0)
PATRIZIA PASANISI ET AL: "A randomized controlled trial of Mediterranean diet and metformin to prevent age-related diseases in people with metabolic syndrome", TUMORI., vol. 104, no. 2, 8 March 2018 (2018-03-08), IT, pages 137 - 142, XP055529738, ISSN: 0300-8916, DOI: 10.5301/tj.5000599 (B1)
ZARRA ET AL: "Efficacy and safety of galantamine in long-term treatment for mild cognitive impairment", ALZHEIMER'S & DEMENTIA: THE JOURNAL OF THE ALZHEIMER'S ASSOCIATION, 1 January 2012 (2012-01-01), pages P586 - P586, XP055528716, Retrieved from the Internet <URL:https://www.sciencedirect.com/science/article/pii/S0924977X11709063/pdfft?md5=4f69e8c045607a471a485e69b3fa2e81&pid=1-s2.0-S0924977X11709063-main.pdf> DOI: 10.1016/j.jalz.2012.05.1596 (B1)
CN-A- 103 860 532 (C0)
CN-B- 104 623 671 (C0)
WO-A1-2009/039313 (C0)
HYE YEON SIN ET AL: "Total cholesterol, high density lipoprotein and triglyceride for cardiovascular disease in elderly patients treated with metformin", ARCHIVES OF PHARMACAL RESEARCH, PHARMACEUTICAL SOCIETY OF KOREA, HEIDELBERG, vol. 34, no. 1, 6 April 2011 (2011-04-06), pages 99 - 107, XP019893772, ISSN: 1976-3786, DOI: 10.1007/S12272-011-0112-5 (B1)
Statushistorie
Hovedstatus | Beslutningsdato, detaljstatus |
---|---|
EP patent gjort gjeldende i Norge | EP patent besluttet gjeldende i Norge |
EP under behandling | Forespørsel om å gjøre EP patent gyldig er mottatt |
Korrespondanse
Dato
Type korrespondanse
Journal beskrivelse
|
---|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Varsel om betaling av første årsavgift (3319) (PTEP3813882)
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Innkommende
EP Publiseringsdokument fra EPO
|
Utgående
EP Registreringsbrev (3210) (PTEP3813882)
|
Innkommende
Korrespondanse (Hovedbrev inn)
|
Utgående
EP Formelle mangler
|
Innkommende
Søknadsskjema Patent
|
Innkommende
EP Publiseringsdokument fra EPO
|
Til betaling:
Betalingshistorikk:
Beskrivelse / Fakturanummer | Betalingsdato | Beløp | Betaler | Status |
---|---|---|---|---|
Årsavgift 6. avg. år (EP) | 2024.07.29 | 2600 | COMPUTER PACKAGES INC. | Betalt og godkjent |
32314284 expand_more expand_less | 2023.11.13 | 5500 | Novagraaf Brevets | Betalt |
Valideringsgebyr EP-patent
5500 = 1 X 5500
|